How Cells Die Determines Whether Immune System Mounts ResponseAn RPB vision researcher's finding could have important implications in the treatment of autoimmune diseases and cancer. Thomas A. Ferguson, Ph.D., Washington University School of Medicine, received an RPB Lew R. Wasserman... Read more...
|
New Vision Screening Device Provides Early Warning of Diabetic Eye DiseaseWatch a video of Dr. Elner explaining the significance of this development for the early detection of diabetes and diabetes-related eye... Read more...
|
Gene Therapy Proven Effective for Patients with Inherited Retinal DiseaseResearchers have used gene therapy to safely restore vision in three young adults with a form of retinitis pigmentosa known as Leber's congenital amaurosis (LCA), an inherited retinal disorder that reduces vision in early childhood and... Read more...
|
RPB-Supported Scientist Revolutionizes Gene ResearchA dramatic new study, supported by Research to Prevent Blindness, questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to... Read more...
|
Macular Degeneration, Diabetic Retinopathy ReversedTwo leading causes of blindness can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. The discovery is an example of basic science research yielding a discovery with direct clinical applications. Read more...
|
New Hope for Regenerating the Human RetinaIn a radical breakthrough, RPB scientists have demonstrated the possibility of chemically signaling the eye's own resources to regenerate retina cells, without transplanting retinal tissue or stem cells. ... Read more...
|
RPB Supports Development of Device for Early Warning of Eye DiseaseAnn Arbor, MI – Scientists at the University of Michigan have shown that their new metabolic imaging instrument can accurately detect eye disease at a very early stage. Such a device would be vision-saving because many severe eye... Read more...
|
RPB Gave $10.94 Million In Grants In 2007New York, NY, January 11, 2008 -- Research to Prevent Blindness (RPB), the leading voluntary health organization supporting eye research, awarded 93 grants totaling $10.94 million in 2007. Departments of ophthalmology at 56 medical... Read more...
|
RPB Supports World Glaucoma DayAs a major contributor to the comprehensive effort to treat, prevent and cure glaucoma, Research to Prevent Blindness is joining with institutions and organizations worldwide to raise awareness about the need to be tested for glaucoma if... Read more...
|
Immune Cell Clues To Age-Related Macular DegenerationAn RPB researcher has found that the age of immune cells, called macrophages, may be key in determining whether damaging blood vessels will form beneath the retina and contribute to vision loss in age-related macular degeneration. A... Read more...
|
RPB Supports Breakthrough Finding In Eye Development, Eye Cancer
Research Uncovers Insufficient Vision Care for Elderly In Nursing Homes
How Research to Prevent Blindness Worked To Advance Ophthalmology
RPB Researcher Identifies Eye Cancer Cell
Artificial Cornea: New Option for the Treatment of Corneal Conditions